Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Ptc Therapeutics (PTCT) Inventory Average: 2017-2025

Historic Inventory Average for Ptc Therapeutics (PTCT) over the last 9 years, with Sep 2025 value amounting to $43.4 million.

  • Ptc Therapeutics' Inventory Average rose 28.52% to $43.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $43.4 million, marking a year-over-year increase of 28.52%. This contributed to the annual value of $26.9 million for FY2024, which is 2.65% up from last year.
  • Ptc Therapeutics' Inventory Average amounted to $43.4 million in Q3 2025, which was up 55.64% from $27.9 million recorded in Q2 2025.
  • Over the past 5 years, Ptc Therapeutics' Inventory Average peaked at $43.4 million during Q3 2025, and registered a low of $14.9 million during Q3 2022.
  • Over the past 3 years, Ptc Therapeutics' median Inventory Average value was $30.3 million (recorded in 2024), while the average stood at $30.8 million.
  • As far as peak fluctuations go, Ptc Therapeutics' Inventory Average spiked by 127.29% in 2023, and later fell by 26.00% in 2025.
  • Ptc Therapeutics' Inventory Average (Quarterly) stood at $15.7 million in 2021, then grew by 16.37% to $18.3 million in 2022, then skyrocketed by 81.13% to $33.2 million in 2023, then dropped by 11.25% to $29.4 million in 2024, then climbed by 28.52% to $43.4 million in 2025.
  • Its Inventory Average stands at $43.4 million for Q3 2025, versus $27.9 million for Q2 2025 and $22.4 million for Q1 2025.